Novartis Partners With Clinton Foundation, Indian And Chinese Drug Makers To Improve Access To Malaria Drugs
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Novartis and the Clinton Foundation have entered into agreements with six Indian and Chinese companies with the objective of lowering the price of malaria drugs and thereby improving access for patients in the developing and underdeveloped world